A detailed history of Verdence Capital Advisors LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 11,794 shares of TECH stock, worth $796,920. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,794
Previous 11,077 6.47%
Holding current value
$796,920
Previous $793,000 18.79%
% of portfolio
0.08%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$70.96 - $82.35 $50,878 - $59,044
717 Added 6.47%
11,794 $942,000
Q2 2024

Jul 25, 2024

SELL
$62.12 - $84.15 $9,877 - $13,379
-159 Reduced 1.42%
11,077 $793,000
Q1 2024

Apr 25, 2024

BUY
$65.98 - $77.09 $298,427 - $348,678
4,523 Added 67.38%
11,236 $790,000
Q4 2023

Jan 31, 2024

SELL
$52.83 - $78.22 $152,414 - $225,664
-2,885 Reduced 30.06%
6,713 $517,000
Q3 2023

Oct 25, 2023

BUY
$67.52 - $89.42 $37,541 - $49,717
556 Added 6.15%
9,598 $653,000
Q2 2023

Jul 28, 2023

BUY
$73.76 - $85.98 $105,181 - $122,607
1,426 Added 18.72%
9,042 $738,000
Q1 2023

Apr 24, 2023

BUY
$71.62 - $86.62 $545,457 - $659,697
7,616 New
7,616 $565,000
Q3 2022

Nov 15, 2022

BUY
$282.54 - $391.85 $11,866 - $16,457
42 Added 2.31%
1,861 $529,000
Q2 2022

Aug 08, 2022

BUY
$322.67 - $449.65 $209,735 - $292,272
650 Added 55.6%
1,819 $631,000
Q1 2022

May 02, 2022

BUY
$353.85 - $487.79 $21,231 - $29,267
60 Added 5.41%
1,169 $506,000
Q4 2021

Jan 26, 2022

SELL
$456.15 - $525.06 $44,246 - $50,930
-97 Reduced 8.04%
1,109 $574,000
Q3 2021

Nov 12, 2021

BUY
$444.87 - $538.88 $138,354 - $167,591
311 Added 34.75%
1,206 $584,000
Q2 2021

Aug 06, 2021

BUY
$387.35 - $450.26 $346,678 - $402,982
895 New
895 $403,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.65B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.